Robertson Stephens Wealth Management LLC Trims Stake in Danaher Co. (NYSE:DHR)

Robertson Stephens Wealth Management LLC reduced its position in Danaher Co. (NYSE:DHR) by 16.0% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 17,240 shares of the conglomerate’s stock after selling 3,294 shares during the period. Robertson Stephens Wealth Management LLC’s holdings in Danaher were worth $3,962,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in DHR. Heck Capital Advisors LLC acquired a new stake in shares of Danaher in the 4th quarter valued at approximately $27,000. Decker Retirement Planning Inc. acquired a new stake in shares of Danaher in the 4th quarter valued at approximately $31,000. Teachers Insurance & Annuity Association of America acquired a new stake in shares of Danaher in the 3rd quarter valued at approximately $39,000. MidAtlantic Capital Management Inc. acquired a new stake in shares of Danaher in the 3rd quarter valued at approximately $40,000. Finally, FSA Wealth Management LLC acquired a new stake in shares of Danaher in the 3rd quarter valued at approximately $50,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Price Performance

Shares of Danaher stock opened at $211.92 on Thursday. Danaher Co. has a twelve month low of $210.04 and a twelve month high of $281.70. The stock has a market capitalization of $153.07 billion, a P/E ratio of 40.14, a PEG ratio of 2.80 and a beta of 0.83. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The business’s fifty day moving average price is $234.50 and its 200 day moving average price is $252.68.

Danaher (NYSE:DHR) last issued its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the company earned $2.09 EPS. As a group, research analysts anticipate that Danaher Co. will post 7.77 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were paid a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.51%. The ex-dividend date was Friday, December 27th. Danaher’s dividend payout ratio is presently 20.45%.

Insiders Place Their Bets

In related news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 10.90% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on DHR shares. Citigroup reduced their price target on Danaher from $285.00 to $265.00 and set a “buy” rating for the company in a report on Thursday, January 30th. TD Cowen lifted their price objective on Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Robert W. Baird reduced their price objective on Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Wells Fargo & Company reduced their price objective on Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a report on Thursday, January 30th. Finally, Bank of America raised Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price target for the company in a research report on Friday, December 13th. Seven research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $278.00.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.